Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook
October 19, 2022 6:00 AM EDTThird quarter GAAP net income was $6.68 per share, including net negative adjustment items of $0.85 per share. Adjusted net income was $7.53* per share. Operating revenue grew 11.5% over the prior year quarter to $39.6 billion. Operating gain grew 10.2% over the prior year quarter to $2.3 billion. Medical enrollment increased 2.2 million members year-over-year and 232 thousand members during the quarter to 47.3 million members. Fourth quarter 2022 dividend of $1.28 per share declared to shareholders.
INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported third quarter 2022 results reflecting strong financial... More
